Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception

Peptides

Volumn 20, Issue 4, 1999, Pages 471-478

  Gupta, Suparna ^a   Pasha, Santosh ^a   Gupta, Y K ^b   Bhardwaj, D K ^c  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Antinociception; Chimeric peptide; FMRFa; MERF; Met enkephalin; Mice; Peripheral; Tolerance

Indexed keywords

CHIMERIC PROTEIN; METENKEPHALIN; MORPHINE; NALOXONE; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STABILITY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; ENKEPHALIN, METHIONINE; FMRFAMIDE; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RECOMBINANT FUSION PROTEINS;

EID: 0032888076     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00028-5     Document Type: Article

References (31)

1. Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide a binding study . Brain Res. 500:1989;169-176.
2. Allard M., Zajac J-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine modulating peptide in rat central nervous system. Neuroscience. 49:1992;101-116.
3. 7, an endogenous neuropeptide, binds to multiple opioid and non-opioid sites in rat brain. J Neurosci Res. 48:1997;249-258.
4. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 72:1941;74-79.
5. Galina H.Z., Kastin A.J. Existence of antiopiate system as illustrated by MIF-1/Tyr-MIF-1. Life Sci. 39:1986;2153-2159.
6. Gicquel S., Mazarguil H., Desprat C., Allard M., Devillers J.P., Simonnet G., Zajac J.M. Structure-activity study of NPFF Contribution of N-terminal regions to affinity and activity . J Med Chem. 37:1994;3477-3481.
7. Goodman C.B., Emilien B., Becketts K., Cadet J.L., Rothman R.B. Down-regulation of μ-opioid binding sites following chronic administration of NPFF and morphine. Peptides. 17:1996;389-397.
8. Goodman C.B., Elmer G.I., Yang H-Y.T., Lee C.H., Rothman R.B. Modulation of opioid receptors by anti-opioid peptides. Tseng L.F. The pharmacology of opioid peptides. 1995;303-319 Harwood Academic Publishers, Singapore, gmbh.
9. Gouarderes C., Sutak M., Zajac J-M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol. 237:1993;73-81.
10. Greenberg M.J., Painter S.D., Doble K.E., Naggle G.T., Price D.A., Lehman H.K. The molluscan neurosecretory peptide FMRFamide comparitive pharmacology and relationship to the enkephalins . Fed Proc. 42:1983;82-86.
11. Gupta S, Pasha S, Gupta YK. Role of hybrid peptide of met-enkephalin and FMRFa in antinociception and its modulation. International Summer Neuropeptide Conference, Key West: Florida; 1997;(Neuropeptides 1997;31(6):609-34).
12. Gupta S, Pasha S, Gupta YK. Role of hybrid peptide of met-enkephalin and FMRFa in antinociception and its modulation. International Summer Neuropeptide Conference, Key West: Florida; 1997;(Neuropeptides 1997;31(6):609-34).
13. 7. Proc Natl Acad Sci USA. 77:(9):1980;5512-5514.
14. Koob G.F., Maldonado R., Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci. 15:1992;186-191.
15. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H-Y.T., Malin D.H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett. 132:1991;29-32.
16. Lake J.R., Hebert K.M., Payza K., Deshotel K.D., Hausum D.D., Witherspoon W.E., Arcangeli K.R., Malin D.H. Analog of NPFF attenuates morphine tolerance. Neurosci Lett. 146:1992;203-206.
17. 7 in rat spinal cord. Brain Res. 264:1983;336-339.
18. 2 like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides. 11:1990;277-280.
19. 2 like mammalian octapeptide possible role in opiate dependence and abstinence . Peptides. 11:1990;969-972.
20. Malin D.H., Lake J.R., Levya J.E., Hammond M.V., Rogillio R.B., Arcangeli K.R., Ludgate K., Moore G.M., Payza K. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides. 12:1991;1011-1014.
21. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ opioid receptor gene. Nature (London). 383:1996;819-823.
22. 2]FMRFamide and other FMRFamide related peptides on mouse colonic propulsive motility a structure-activity relationship study . J Pharmacol Exp Ther. 254:1990;809-814.
23. 2b receptors. Peptides. 15:(3):1994;401-404.
24. 2]FMRFamide's mixed action in vivo? Peptides. 17:(8):1996;1261-1265.
25. 7, present in high amounts in brain of rat, cattle and man, is an opioid agonist. Nature. 288:(6):1980;88-90.
26. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
27. Schwyzer R. 100 years Lock and Key concept are peptide keys shaped and guided to their receptors by the target cell membrane? Biopolymers (Peptide Science). 37:1995;5-16.
28. 7] from bovine adrenal medullary granules and striatum. Proc Natl Acad Sci USA. 76:1997;6680-6683.
29. 2 -like immunoreactivity. Proc Natl Acad Sci USA. 81:1984;5002-5005.
30. Yang H-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA. 82:1982;7757-7761.
31. 7 stored in various rat brain regions. J Neurochem. 40:1983;969-976.